Earnings:
Microsoft is expected to post another strong quarter of growth postmarket as consumers shift to cloud computing, with Goldman seeing signs of solid demand.
Eli Lilly's earnings missed and it flagged a $400 million expense related to Covid R&D. It reaffirmed its forecast for the year. Shares slipped premarket.
Merck raised its forecast after a third-quarter beat. It now sees full-year adjusted EPS of $5.91 to $6.01 compared with an earlier forecast of $5.63 to $5.78. Shares rose 1%.
Pfizer narrowed its revenue guidance to $48.8 billion to $49.5 billion from $48.6 billion to $50.6 billion earlier. Adjusted EPS of 72 cents beat consensus of 71 cents. The stock fell.
Caterpillar beat but reported lower sales in all regions. Shares fell premarket.
BP eked out a small profit, defying expectations for a loss.
3M reported better-than-expected adjusted EPS of $2.43.
Harley-Davidson jumped 8% premarket after reporting adjusted EPS that smashed estimates.
Microsoft is expected to post another strong quarter of growth postmarket as consumers shift to cloud computing, with Goldman seeing signs of solid demand.
Eli Lilly's earnings missed and it flagged a $400 million expense related to Covid R&D. It reaffirmed its forecast for the year. Shares slipped premarket.
Merck raised its forecast after a third-quarter beat. It now sees full-year adjusted EPS of $5.91 to $6.01 compared with an earlier forecast of $5.63 to $5.78. Shares rose 1%.
Pfizer narrowed its revenue guidance to $48.8 billion to $49.5 billion from $48.6 billion to $50.6 billion earlier. Adjusted EPS of 72 cents beat consensus of 71 cents. The stock fell.
Caterpillar beat but reported lower sales in all regions. Shares fell premarket.
BP eked out a small profit, defying expectations for a loss.
3M reported better-than-expected adjusted EPS of $2.43.
Harley-Davidson jumped 8% premarket after reporting adjusted EPS that smashed estimates.